FI752487A - - Google Patents

Info

Publication number
FI752487A
FI752487A FI752487A FI752487A FI752487A FI 752487 A FI752487 A FI 752487A FI 752487 A FI752487 A FI 752487A FI 752487 A FI752487 A FI 752487A FI 752487 A FI752487 A FI 752487A
Authority
FI
Finland
Application number
FI752487A
Other languages
Finnish (fi)
Inventor
Michael Barrie Thomas
Michael Trevelyn Williams
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI752487A publication Critical patent/FI752487A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI752487A 1974-09-06 1975-09-04 FI752487A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3914374A GB1463520A (en) 1974-09-06 1974-09-06 Process for the production of imidazolines

Publications (1)

Publication Number Publication Date
FI752487A true FI752487A (fr) 1976-03-07

Family

ID=10407882

Family Applications (1)

Application Number Title Priority Date Filing Date
FI752487A FI752487A (fr) 1974-09-06 1975-09-04

Country Status (12)

Country Link
JP (1) JPS51149291A (fr)
BE (1) BE833135A (fr)
CA (1) CA1043791A (fr)
DE (1) DE2538620A1 (fr)
DK (1) DK398775A (fr)
ES (1) ES440760A1 (fr)
FI (1) FI752487A (fr)
FR (1) FR2283899A1 (fr)
GB (1) GB1463520A (fr)
LU (1) LU73327A1 (fr)
NL (1) NL7510473A (fr)
SE (1) SE7509271L (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198442A (en) * 1989-10-12 1993-03-30 Allergan, Inc. (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same
US5112822A (en) * 1989-10-12 1992-05-12 Allergan, Inc. (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same
US5326763A (en) * 1989-10-12 1994-07-05 Allergan, Inc. Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
US5204347A (en) * 1989-10-12 1993-04-20 Allergan, Inc. Methods for using (2-imidazolin-2-ylamino) tetrahydroquinoxalines
US5077292A (en) * 1989-10-12 1991-12-31 Allergan, Inc. (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same
US5021416A (en) * 1989-10-31 1991-06-04 Allergan, Inc. Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure
US5237072A (en) * 1990-02-06 1993-08-17 Allergan, Inc. Method for producing amino-2-imidazoline derivatives
US5130441A (en) * 1990-02-06 1992-07-14 Allergan, Inc. Method for producing amino-2-imidazoline derivatives
WO1995010280A1 (fr) * 1993-10-13 1995-04-20 Allergan Modes d'utilisation de derives de la quinoxaline (2 - imidazolin - 2 - ylamino)
US6323204B1 (en) 1993-10-13 2001-11-27 Allergan Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
CA2505836C (fr) 2004-05-06 2013-08-27 Alcon Inc. Formulations topiques de tartrate de brimonidine exemptes de dioxyde de chlore
EP3086776B1 (fr) 2013-12-24 2020-06-17 Sentiss Pharma Private Limited Solution ophthalmique topique de tartrate de brimonidine
JP6339364B2 (ja) * 2013-12-27 2018-06-06 カズマパートナーズ株式会社 無定形ブリモニジン酒石酸塩及びその製造方法
JP6270603B2 (ja) * 2014-04-14 2018-01-31 カズマパートナーズ株式会社 ブリモニジン酒石酸塩の新規多形及びその製造方法
EP4142689A1 (fr) 2020-04-29 2023-03-08 Sentiss Pharma Private Limited Compositions ophtalmiques comprenant une combinaison de brinzolamide et de brimonidine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795970A (fr) * 1972-02-29 1973-08-27 Pfizer Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant

Also Published As

Publication number Publication date
DK398775A (da) 1976-03-07
JPS51149291A (en) 1976-12-22
BE833135A (fr) 1976-03-05
DE2538620A1 (de) 1976-03-18
NL7510473A (nl) 1976-03-09
SE7509271L (sv) 1975-12-29
ES440760A1 (es) 1977-04-01
FR2283899A1 (fr) 1976-04-02
CA1043791A (fr) 1978-12-05
LU73327A1 (fr) 1977-05-11
GB1463520A (en) 1977-02-02
AU8430575A (en) 1977-03-03

Similar Documents

Publication Publication Date Title
BR7501663A (fr)
FI752487A (fr)
FI753004A (fr)
FR2292564B2 (fr)
JPS50119164A (fr)
IN142759B (fr)
JPS50105713U (fr)
AU7459374A (fr)
JPS50135956A (fr)
JPS50139342U (fr)
AU495028B2 (fr)
JPS50117776U (fr)
AU481101A (fr)
BG26507A3 (fr)
BG26511A3 (fr)
BG26512A3 (fr)
BG27063A3 (fr)
BG27078A3 (fr)
BG22843A3 (fr)
CH1092674A4 (fr)
AU480143A (fr)
AU480625A (fr)
BG20425A1 (fr)
AU481523A (fr)
BG22275A1 (fr)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: PFIZER CORPORATION